What Companies should know about PMCs and Biocidal Products

Companies distributing Medical Surgical Aids (Presidi Medico-Chirurgici, PMCs) have been facing for a long time a significant change in regulations: the progressive transition toward Regulation (EU) no. 528/2012 on biocides.
This evolution of the regulations is a real challenge for many companies, especially for SMEs, requested to adjust to requirements that are becoming more and more cogent in terms of authorisation, preparation of the technical dossier and regulatory management, to be able to continue to operate in the European market in compliance with the new rules.
The provisions of the Biocidal Products Regulation 528/2012
Regulation (EU) 528/2012 introduced a harmonised system at European level for the authorisation and marketing of biocidal products. The Regulation goal is to ensure the protection of human health and environment, imposing strict requirements and a centralised management via the European portal R4BP3.
In Italy, PMCs are currently subject to a national regulation, the Presidential decree 392/1998, but only transitorily: once the active substance evaluation phase (by the European Commission) is over, the product shall be authorised as a biocidal product according to the provisions of the EU Regulation.
Why should company act now?
Many companies risk to find themselves unprepared in front of:
- Forthcoming deadlines on the approval of active substances
- High costs for the preparation of the dossier according to the European standards
- Long timelines for the assessment by competent authorities.
On the other hand, a proactive approach and an appropriate regulatory planning, allow to:
- Be ready at the deadline
- Consider strategic alternatives
- Maintain market continuity for one’s product portfolio
Companies’ questions
1. Must my PMC become a biocidal product?
Yes, if it contains an active substance approved at European level for the specific product type (PT).
2. Until when can I authorise my new PMC?
Until a year before the date of approval of the biocidal active substance referred to the PT of interest.
3. How can I know if the active substance was approved?
It is possible to consult the official list of the approved active substances in the ECHA website, or request a technical evaluation from a regulatory consultant such as Di Renzo Regulatory Affairs, that is able to provide an updated and detailed analysis.
4. What is needed to authorise a biocidal product?
To obtain the authorisation, it is requested to submit a well-structured technical dossier, including:
- Chemical-physical analyses
- Toxicologic and eco-toxicological data
- Studies on the product efficacy
- Information on the composition
- Labelling and use conditions
The dossier should be uploaded into and managed via the European portal R4BP3, and can follow different pathways: national authorisation, mutual recognition authorisation (in parallel or in sequence) or Union authorisation.
5. How much does it cost to authorise a biocidal product?
Costs vary based on:
- Type of procedure (national, mutual recognition, Union)
- Type of product and number of markets involved
- Need of integrative studies
For a SME, cost may become significant: for this reason, it is advisable to evaluate collective strategies, such as the access to existing dossiers (via Letter of access), or the formulation of a family of biocidal products.
How can Di Renzo Regulatory Affairs support companies in the sector of biocidal products and PMCs?
With their in-depth knowledge of the national Italian regulations on PMCs as well as of the UE Biocidal Products Regulation, Di Renzo Regulatory Affairs is the ideal partner that can support companies in this delicate transition.
Among other services, we also offer:
- Feasibility studies to identify the correct procedure to be followed to authorise the product.
- Evaluation of the active substances at European level
- Assessment on the completeness of the dossier provided
- Drafting of the Summary of product characteristics (SPC) via EUCLID
- Interaction with the ECHA as well as national authorities
- Full support in the use of the R4BP3 system
The transition from PMC to biocides regulated at European level has already started and will progressively involve all the companies operating in this sector.
The companies capable of a timely planning and trusting expert consultants will be able to maintaining their competitiveness, avoiding disruptions in the marketing of their products and optimising time and costs.
Contact us for a quick check of your product portfolio and find out how we can help you to turn regulation compliance into a competitive advantage.
Previous Post
Next Post